HMOs are complex sugars naturally found in breast milk. HMOs are the third most abundant solid ingredient in breast milk, following lactose and lipids. As they are not digested by the infant, HMOs reach the colon intact. They nourish beneficial gut bacteria, block harmful microbes, and support the developing immune system. Research shows that HMOs also contribute to gut barrier function and early cognitive development, making them essential to infant health.

Each HMO plays a unique biological role, from enhancing gut barrier to supporting the gut microbiome. Using multiple HMOs creates a broader health impact, mimicking the natural diversity found in breast milk.

We currently offer six HMOs at commercial scale:
‍
2'-Fucosyllactose (2'-FL)
3-Fucosyllactose (3-FL)
3’-Sialyllactose (3’-SL)
6’-Sialyllactose (6’-SL)
Lacto-N-Tetraose (LNT)
Lacto-N-Neotetraose (LNnT)

Each comes with regulatory documentation, technical specs and research data.

Inbiose uses precision fermentation and synthetic biology to produce HMOs sustainably and at commercial scale. Our proprietary platform enables cost-efficient and high-yield production. Scientists design safe bacteria, similar to those used for making vitamins or enzymes, to ferment and create HMOs. Once fermentation is complete, the mixture is purified to remove the bacteria, yielding a clean, high-purity HMO that’s chemically identical to those found in breast milk.